Clinical Trials Directory

Trials / Completed

CompletedNCT01957423

Immune Response Regulation and Nutritional Status of the Crohn's Disease Patients.

Immune Response Regulation and Nutritional Status of Crohn's Disease Patients Under Anti-TNF-alpha and Azathioprine Therapy.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
41 (actual)
Sponsor
University of Campinas, Brazil · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The objective of this study was to evaluate the effect of Whey Protein (WP) and Soy Protein (SP) nutritional supplements on nutritional status and disease activity in Crohn's disease patients.

Detailed description

The patients were split into two groups: one group was supplemented with whey protein and the other, with soy protein. Participants were assessed at three moments: before starting the intervention and after 8 and 16 weeks. The nutritional status and body composition were measured using bioimpedance analysis, anthropometry and albumin and pre-albumin dosages. Dietary intake was determined by 24-h dietary recalls. The disease activity was evaluated by Crohn's Disease Activity Index, serum cytokines and C-reactive protein dosages.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhey proteinWhey protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.
DIETARY_SUPPLEMENTSoy proteinSoy protein was provided as sachets with 15g. Patients were advised to consume two sachets per day (amounting to 22.4g of protein) mixed with food or a cold beverage, for 16 weeks. All patients remained on an unrestricted diet and did not receive nutritional advice.

Timeline

Start date
2012-03-01
Primary completion
2013-03-01
Completion
2013-03-01
First posted
2013-10-08
Last updated
2013-10-08

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01957423. Inclusion in this directory is not an endorsement.